Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FX1ZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On July 10, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $48,750 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Stelara 90 mg/mL syringes, a biologic immunosuppressant medication, with an ultimate completion date of July 31, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $500 million and extends through November 2026. This master contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a consistent track record of delivering specialized pharmaceutical products directly to Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FX1ZG?
SPE2DB25FX1ZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FX1ZG worth?
The government has obligated $48,750 on SPE2DB25FX1ZG.
Is contract SPE2DB25FX1ZG an order under another contract?
Yes. SPE2DB25FX1ZG is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1ZG competed?
The extent of competition for SPE2DB25FX1ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award